Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
The Zinc finger and SCAN domain containing 5A pseudogene (ENSG00000259273) is a non-functional genomic element with sequence similarity to the canonical ZSCAN5A gene. Pseudogenes commonly arise from gene duplication or retrotransposition events and contain disruptions that prevent them from encoding a functional protein[2]. The parent gene ZSCAN5A is a transcription factor with both zinc finger DNA-binding domains and a SCAN domain that mediates protein-protein interactions and self-association, but the pseudogene does not retain these functional capabilities[1][3][6]. Pseudogenes do not participate in signal transduction, metabolic reactions, or serve as drug targets; their role in health and disease is generally limited to possible genomic regulation as non-coding elements, but no specific biological or clinical associations are reported for this pseudogene[2][5].
None (no drugs interact; pseudogenes have no mechanism of action in response to drug treatment)
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Zinc finger and SCAN domain containing 5A pseudogene (ZSCAN5A pseudogene).